EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhanced In Vitro Stability of Bedaquiline with Ascorbic Acid and Pyruvate During Long-Term Incubation in Mycobacterium Species

Sara Batista, Jordi Lamata, Lidia Feliu iD, Marta Planas iD, Mariana Fernandez-Pittol, Diego Martinez, Lorena San Nicolás, Griselda Tudó iD, Julian Gonzalez-Martin iD

Antibiotics · 20.03.2026 · 15 (3) · 316

DOI: 10.3390/antibiotics15030316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 20.03.2026. Verfasst von Sara Batista und 8 weiteren Autor:innen. Beteiligte Einrichtung: Departament de Fonaments Clínics, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, c/Casanova 143, 08036 Barcelona, Spain. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Economía y Competitividad, Instituto de Salud Carlos III, cofinanced by the European Regional Development Fund (ERDF, FEDER), "A Way to Achieve E…, Sociedad Española de Neumología y Cirugía Torácica (SEPAR), Departament d'Universitats, Recerca i Societat de la Informació de la Generalitat de Catalunya.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Drug susceptibility testing in Mycobacterium species typically requires prolonged incubation periods during which the chemical integrity of antibiotics may not be maintained, potentially compromising the reliability and accuracy of minimum inhibitory concentration (MIC) determinations.

Objectives

This study evaluated the in vitro stability of several antibiotics, including recently introduced agents (bedaquiline [BDQ], pretomanid, delamanid and clofazimine) used for treating multidrug-resistant mycobacteriosis (linezolid and moxifloxacin), and those commonly included in combination regimens (rifampicin, isoniazid, ethambutol and clarithromycin).

Methods

Antibiotics were pre-incubated at 37 °C before MIC determination and those exhibiting two or more dilutions in MIC were further tested in combination with ascorbic acid (AA) and pyruvate (P).

Results

All antibiotics demonstrated stability except BDQ, which showed significant MIC variation after pre-incubation, which was prevented when BDQ was combined with AA and P.

Conclusions

These findings suggest that the combined use of AA and P may serve as an effective stabilizing strategy for BDQ during MIC determination.

Schlagwörter

Stichwörter der Autor:innen

Mycobacterium avium complexMycobacterium tuberculosisantibiotic stabilityantimicrobial susceptibility testascorbic acidbedaquilineminimum inhibitory concentration (MIC)pyruvate

Autor:innen und Institutionen

  • Departament de Fonaments Clínics, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, c/Casanova 143, 08036 Barcelona, Spain.
  • Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques Augustí Pi i Sunyer (FRCB-IDIBAPS), 08036 Barcelona, Spain.
  • Servei de Microbiologia, CDB, Hospital Clínic de Barcelona, c/Villarroel 170, 08036 Barcelona, Spain.
  • LIPPSO, Departament de Química, Institut de Tecnologia Agroalimentària, Universitat de Girona, Maria Aurèlia Capmany 69, 17003 Girona, Spain.
  • ISGlobal Barcelona, Institute for Global Health, 08036 Barcelona, Spain.
  • CIBER of Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.

ORCID-Profile: Lidia Feliu, Marta Planas, Griselda Tudó, Julian Gonzalez-Martin

Förderung

  • Ministerio de Economía y Competitividad, Instituto de Salud Carlos III, cofinanced by the European Regional Development Fund (ERDF, FEDER), "A Way to Achieve E…
  • Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
  • Departament d'Universitats, Recerca i Societat de la Informació de la Generalitat de Catalunya
  • Fundació La Marató de TV3
  • CIBER- Consorcio Centro de Investigación Biomédica en Red, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, and Unión Europea-NextGenerationEU

Zitieren

APA

Batista, S., Lamata, J., Feliu, L., Planas, M., Fernandez-Pittol, M., Martinez, D., San Nicolás, L., Tudó, G., & Gonzalez-Martin, J. (2026). Enhanced In Vitro Stability of Bedaquiline with Ascorbic Acid and Pyruvate During Long-Term Incubation in Mycobacterium Species. Antibiotics, 15(3), 316. https://doi.org/10.3390/antibiotics15030316

Vancouver

Batista S, Lamata J, Feliu L, Planas M, Fernandez-Pittol M, Martinez D, et al. Enhanced In Vitro Stability of Bedaquiline with Ascorbic Acid and Pyruvate During Long-Term Incubation in Mycobacterium Species. Antibiotics. 2026;15(3):316. doi:10.3390/antibiotics15030316

BibTeX
@article{Batista2026,
  author = {Batista, Sara and Lamata, Jordi and Feliu, Lidia and Planas, Marta and Fernandez-Pittol, Mariana and Martinez, Diego and San Nicolás, Lorena and Tudó, Griselda and Gonzalez-Martin, Julian},
  title = {Enhanced In Vitro Stability of Bedaquiline with Ascorbic Acid and Pyruvate During Long-Term Incubation in Mycobacterium Species},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {3},
  pages = {316},
  doi = {10.3390/antibiotics15030316}
}
Kostenlos starten →